Current Neuro-Oncology
Volume
25 Number 11
15 June 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 11, 15 June
Fujii K, Hirano S, Kurozumi K, Date I.
A
Case of High-Grade Glioma in an Eloquent Area Treated with Awake
Craniotomy in an 85-year-old Patient.
Acta
Med Okayama. 2023 Jun;77(3):335-340∟.
doi: 10.18926/AMO/65504∟.
PMID: 37357636∟.
Case report. ˍ
Boroun A, Gholamhosseinian H, Montazerabadi A, Molana SH, Pashaei
F.
Optimizing the Radiation Treatment
Planning of Brain Tumors by Integration of Functional MRI and
White Matter Tractography.
J Biomed Phys Eng. 2023 Jun
1;13(3):239-250∟.
doi: 10.31661/jbpe.v0i0.2210-1547? PMID: 37312891∟.
Observational study. ˍ
Christ SM, Willmann J, Heesen P, Kühnis A, Tanadini-Lang S,
Looman EL, Ahmadsei M, Blum D, Guckenberger M, Balermpas P,
Hertler C, Andratschke N.
Mortality
during or shortly after Curative-Intent Radio-(Chemo-)Therapy over
the last decade at a large comprehensive cancer center.
Clin
Transl Radiat Oncol. 2023 Jun 1;41:100645∟.
doi: 10.1016/j.ctro.2023.100645∟.
PMID: 37304171∟.
Observational study. ˍ
Caccese M, Desideri I, Padovan M, Bruno F, Cerretti G, Fiorentino
A, Denaro L, Chioffi F, Della Puppa A, Maccari M, Cavallin F,
Coppola M, Pittaro A, Rudà R, Livi L, Lombardi
G.
Association between thyroid function
and regorafenib efficacy in patients with relapsed wild-type IDH
glioblastoma: a large multicenter study.
J
Neurooncol. 2023 Jun 1∟.
doi: 10.1007/s11060-023-04356-w∟.
PMID: 37264256∟.
Observational study. ˍ
Eltoukhy M, Kandula V, Joseph S, Albanese E, Giridharan S.
"Should
Redo Surgery be Offered to Patients with Relapsed Glioblastoma? -
Outcome analyses of a single institution comparative cohort
study".
World
Neurosurg. 2023 Jun 1:S1878-8750(23)00729-5∟.
doi: 10.1016/j.wneu.2023.05.097∟.
PMID: 37268188∟.
Observational study˰ ˍ
*
Garcez PP, Guasti A, Ventura N, Higa LM, Andreiuolo F, de Freitas
GPA, Ribeiro LJ, Maia RA, de Lima SMB, de Souza Azevedo A,
Schwarcz WD, Caride EC, Chimelli L, Dubois LG, Ferreira Júnior
ODC, Tanuri A, Moura-Neto V, Niemeyer P.
Case
report: Regression of Glioblastoma after flavivirus
infection.
Front Med
(Lausanne). 2023 Jun 1;10:1192070∟.
doi: 10.3389/fmed.2023.1192070∟.
PMID: 37324152∟.
Case report. ˍ
Shafizadeh M, Farzaneh F, Kankam SB, Jangholi E, Shafizadeh Y,
Khoshnevisan A.
Effects of
postoperative intravenous Cyclosporine treatement on the survival
and functional performance status of patients with glioblastoma: A
randomized, triple-blinded, placebo-controlled clinical
trial.
World Neurosurg.
2023 Jun 1:S1878-8750(23)00733-7∟.
doi: 10.1016/j.wneu.2023.05.101∟.
PMID: 37268192∟.
Interventional study˰ ˍ
Yang W, Ma W, Huang J, Cai Y, Peng X, Zhao F, Zhang D, Zou Z, Sun
H, Qi X, Ge M.
Beijing Children's
Hospital guidelines on the design and conduction of the first
standardized database for medulloblastoma.
Metab
Brain Dis. 2023 Jun 1∟.
doi: 10.1007/s11011-023-01233-3∟.
PMID: 37261631∟.
Observational study˰ ˍ
Aleid AM, Alaethan MH, Alsaati AA, Alhejji MH, Ali Alkathem
J.
Medullary brainstem gliomas in an
adult: A rare case report and challenging tumor.
Surg
Neurol Int. 2023 Jun 2;14:190∟.
doi: 10.25259/SNI_189_2023∟.
PMID: 37404499∟.
Case report. ˍ
Früh A, Schaumann A, Cohrs G, Pennacchietti V, Schulz M,
Hernáiz Driever P, Koch A, Thomale UW.
Biopsies
of caudal brainstem tumors in pediatric patients - a single center
retrospective case series.
World
Neurosurg. 2023 Jun 2:S1878-8750(23)00754-4∟.
doi: 10.1016/j.wneu.2023.05.108∟.
PMID: 37271255∟.
Observational study˰ ˍ
Xi C, Jinli S, Jianyao M, Yan C, Huijuan L, Zhongjie S, Zhangyu L,
Liwei Z, Yukui L, Sifang C, Guowei T.
Fluorescein-guided
surgery for high-grade glioma resection: a five-year-long
retrospective study at our institute.
Front
Oncol. 2023 Jun 2;13:1191470∟.
doi: 10.3389/fonc.2023.1191470∟.
PMID: 37333818∟.
Observational study. ˍ
Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters
KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F,
Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y,
Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la
Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L,
Hassan I, Wen PY, Cloughesy TF.
Vorasidenib
in IDH1- or IDH2-Mutant Low-Grade Glioma.
N
Engl J Med. 2023
Jun 4. doi:
10.1056/NEJMoa2304194. PMID:
37272516. Interventional study. ˍ
*
Fine H, Reid T, Caroen S, Oronsky B, Abrouk N, Butowski N.
A
multicenter, phase 1, dose escalation clinical trial (G-FORCE-1)
of XRT, RRx-001 and temozolomide followed by temozolomide +/-
RRx-001 in newly diagnosed glioblastoma.
Front
Oncol. 2023 Jun 5;13:1176448∟.
doi: 10.3389/fonc.2023.1176448∟.
PMID: 37342189∟.
Interventional study. ˍ
Robles-Castro J, Niembro-Zúñiga A, Ortiz-Azpilcueta
M, Betanzos-Cabrera Y, Arreguín-González F,
Barrera-Villegas G, Ortiz-Morales D, Arroyo-Acosta JB,
Zapata-Tarrés M.
Diffuse
intrinsic pontine gliomas: First registry effort in
Mexico.
Pediatr Blood
Cancer. 2023 Jun 5:e30431∟.
doi: 10.1002/pbc.30431∟.
PMID: 37277314∟.
Observational study˰ ˍ
Yoon WS, Chang JH, Kim JH, Kim YJ, Jung TY, Yoo H, Kim SH, Ko YC,
Nam DH, Kim TM, Kim SH, Park SH, Lee YS, Yim HW, Hong YK, Yang
SH.
Efficacy and safety of metformin
plus low-dose temozolomide in patients with recurrent or
refractory glioblastoma: a randomized, prospective, multicenter,
double-blind, controlled, phase 2 trial (KNOG-1501 study).
Discov
Oncol. 2023 Jun 6;14(1):90∟.
doi: 10.1007/s12672-023-00678-3∟.
PMID: 37278858∟.
Interventional study. ˍ
Weller J, Katzendobler S, Niedermeyer S, Harter PN, Herms J, Trumm
C, Niyazi M, Thon N, Tonn JC, Stoecklein VM.
Treatment
benefit in patients aged 80 years or older with biopsy-proven and
non-resected glioblastoma is dependent on MGMT promoter
methylation status.
J
Neurooncol. 2023 Jun 8∟.
doi: 10.1007/s11060-023-04362-y∟.
PMID: 37289281∟.
Observational study. ˍ
You WC, Lee HD, Pan HC, Chen HC.
Re-irradiation
combined with bevacizumab for recurrent glioblastoma beyond
bevacizumab failure: survival outcomes and prognostic factors.
Sci
Rep. 2023 Jun 9;13(1):9442∟.
doi: 10.1038/s41598-023-36290-2∟.
PMID: 37296207∟.
Observational study. ˍ
Ehret F, Wolfgang J, Allwohn L, Onken J, Wasilewski D, Roohani S,
Oertel J, Zips D, Kaul D.
Outcomes of
Isocitrate Dehydrogenase Wild Type Glioblastoma after
Re-irradiation.
Clin
Transl Radiat Oncol. 2023 Jun 13;42:100653∟.
doi: 10.1016/j.ctro.2023.100653∟.
PMID: 37502699∟.
Observational study. ˍ
Gong X, Kuang S, Deng D, Wu J, Zhang L, Liu C.
Differences
in survival prognosticators between children and adults with
H3K27M-mutant diffuse midline glioma.
CNS
Neurosci Ther. 2023 Jun 13∟.
doi: 10.1111/cns.14307∟.
PMID: 37311690∟.
Observational study. ˍ
Liu H, Sun P.
A Nomogram Model for
Predicting Prognosis of Patients with Medulloblastoma.
Turk
Neurosurg. 2023 Jun 13∟.
doi: 10.5137/1019-5149.JTN.40397-22.3? PMID: 37309623∟.
Observational study. ˍ
Sandler CX, Gildea GC, Spence RR, Jones TL, Eliadis P, Walker D,
Donaghue A, Bettington C, Keller J, Pickersgill D, Shevill M,
Biggs V, Morrison B, Jonker F, Foote M, Bashford J, Hayes SC.
The
safety, feasibility, and efficacy of an 18-week exercise
intervention for adults with primary brain cancer - the BRACE
study.
Disabil Rehabil.
2023 Jun 13:1-10∟.
doi: 10.1080/09638288.2023.2221041∟.
PMID: 37310040∟.
Interventional study˰ ˍ
McClelland S 3rd, Sun Y, Spratt
DE.
Spine
Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic
Neoplasms (SPORTSMEN): a randomized phase II study protocol.
Rep
Pract Oncol Radiother. 2023 Jun 14;28(3):379-388∟.
doi: 10.5603/RPOR.a2023.0037∟.
PMID: 37795393∟.
Interventional study protocol. ˍ
Delacourt L, Allodji R, Chappat J, Haddy N, El-Fayech C,
Demoor-Goldschmidt C, Journy N, Bolle S, Thomas-Teinturier C,
Zidane M, Rubino C, Veres C, Vu-Bezin G, Berchery D, Pluchart C,
Bondiau PY, Dumas A, Bougas N, Grill J, Dufour C, Fresneau B,
Pacquement H, Diallo I, Doz F, de Vathaire F.
Risk
factors for obesity in adulthood among survivors of childhood
cancer.
Obesity (Silver
Spring). 2023 Jun 15∟.
doi: 10.1002/oby.23784∟.
PMID: 37318080∟.
Observational study˰ ˍ
*
La Rosa A, Gutierrez AN, Odia Y, McDermott MW, Ahluwalia MS, Mehta
MP, Kotecha R.
Temporally modulated
pulsed proton re-irradiation (TMPPR) for recurrent high-grade
gliomas.
Neurooncol
Adv. 2023 Jun 15;5(1):vdad074∟.
doi: 10.1093/noajnl/vdad074∟.
PMID: 37358937∟.
Case report. ˍ
Mueller S, Kline C, Stoller S, Lundy S, Christopher L, Reddy AT,
Banerjee A, Cooney TM, Raber S, Hoffman C, Luks T,
Wembacher-Schroeder E, Lummel N, Zhang Y, Bonner ER, Nazarian J,
Molinaro AM, Prados M, Villanueva-Meyer JE, Gupta N.
PNOC015:
Repeated convection enhanced delivery (CED) of MTX110 (aqueous
panobinostat) in children with newly diagnosed diffuse intrinsic
pontine glioma (DIPG).
Neuro Oncol. 2023 Jun
15:noad105∟.
doi: 10.1093/neuonc/noad105∟.
PMID: 37318058∟.
Interventional study˰ ˍ
Rameh V, Vajapeyam S, Ziaei A, Kao P, London WB, Baker SJ, Chiang
J, Lucas J, Tinkle CL, Wright KD, Poussaint TY.
Correlation
between Multiparametric MR Imaging and Molecular Genetics in
Pontine Pediatric High-Grade Glioma.
AJNR
Am J Neuroradiol. 2023 Jun 15∟.
doi: 10.3174/ajnr.A7910∟.
PMID: 37321859∟.
Observational study. ˍ